Amgen IncAMGN
▲ ポジティブ資本関連度
StockStory highlights Amgen as having sustainable market-beating potential with strong revenue growth and free cash flow.
資産への影響 3
Biotech & Genomic Medicine
Amgen Inc
Medpace Holdings IncMEDP
▲ ポジティブ資本関連度
StockStory highlights Medpace as having sustainable market-beating potential with strong organic revenue growth and expanding free cash flow margin.
Health Care
Goodrx Holdings IncGDRX
▼ ネガティブ資本関連度
StockStory recommends avoiding GoodRx due to flat sales, negative returns on capital, and lack of scale.